Diametric Capital, LP Chimerix Inc Transaction History

Diametric Capital, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $25,141 - $100,189	18,762 Added 6.88%	291,611 $607,000
Q1 2022 May 16, 2022	BUY	$4.58 - $6.8 $438,347 - $650,821	95,709 Added 54.03%	272,849 $1.25 Million
Q4 2021 Feb 14, 2022	BUY	$5.23 - $7.18 $459,544 - $630,885	87,867 Added 98.43%	177,140 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.75 $101,948 - $150,176	17,163 Added 23.8%	89,273 $553,000
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $543,709 - $705,956	72,110 New	72,110 $577,000
Q1 2021 May 17, 2021	SELL	$4.76 - $11.25 $430,232 - $1.02 Million	-90,385 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.43 - $5.42 $268,609 - $599,121	-110,539 Reduced 55.02%	90,385 $437,000
Q3 2020 Nov 13, 2020	SELL	$2.3 - $3.72 $162,853 - $263,398	-70,806 Reduced 26.06%	200,924 $500,000
Q2 2020 Aug 14, 2020	BUY	$1.33 - $3.63 $361,400 - $986,379	271,730 New	271,730 $842,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.